Search research articles
Contact Us
Filters
Showing results (401-410 of 421) with videos related to
Page
of 43
Sort By:
European Journal of Gastroenterology & Hepatology
|
February 17, 2016
Comprehensive epidemiological and genotype-phenotype analyses in a large European sample with idiopathic achalasia
Jessica Becker, Stefan Niebisch, Arcangelo Ricchiuto, et al.
Journal of Critical Care
|
November 15, 2024
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19
Laurence W Busse, J Pedro Teixeira, Christopher L Schaich, et al.
British Journal of Cancer
|
August 4, 2023
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience
Julius C Enßle, Sebastian Wolf, Sebastian Scheich, et al.
Haematologica
|
August 16, 2019
<i>EZH2</i> mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia
Sebastian Stasik, Jan M Middeke, Michael Kramer, et al.
Blood Cancer Journal
|
January 24, 2023
Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
Jan-Niklas Eckardt, Sebastian Stasik, Christoph Röllig, et al.
The Lancet. Haematology
|
April 7, 2024
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, et al.
Blood Cancer Journal
|
May 26, 2023
UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome
Julia-Annabell Georgi, Sebastian Stasik, Jan-Niklas Eckardt, et al.
Blood Advances
|
August 30, 2021
Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
Sebastian Stasik, Jan-Niklas Eckardt, Michael Kramer, et al.
Cancers
|
April 30, 2021
Loss-of-Function Mutations of <i>BCOR</i> Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia
Jan-Niklas Eckardt, Sebastian Stasik, Michael Kramer, et al.
Haematologica
|
April 24, 2024
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens
David Baden, Sven Zukunft, Gema Hernandez, et al.
Page
of 43
Search research articles
Search
Showing results (401-410 of 421) with videos related to
Sort By:
Page
of 43
European Journal of Gastroenterology & Hepatology
|
February 17, 2016
Comprehensive epidemiological and genotype-phenotype analyses in a large European sample with idiopathic achalasia
Jessica Becker, Stefan Niebisch, Arcangelo Ricchiuto, et al.
Journal of Critical Care
|
November 15, 2024
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19
Laurence W Busse, J Pedro Teixeira, Christopher L Schaich, et al.
British Journal of Cancer
|
August 4, 2023
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience
Julius C Enßle, Sebastian Wolf, Sebastian Scheich, et al.
Haematologica
|
August 16, 2019
<i>EZH2</i> mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia
Sebastian Stasik, Jan M Middeke, Michael Kramer, et al.
Blood Cancer Journal
|
January 24, 2023
Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
Jan-Niklas Eckardt, Sebastian Stasik, Christoph Röllig, et al.
The Lancet. Haematology
|
April 7, 2024
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, et al.
Blood Cancer Journal
|
May 26, 2023
UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome
Julia-Annabell Georgi, Sebastian Stasik, Jan-Niklas Eckardt, et al.
Blood Advances
|
August 30, 2021
Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
Sebastian Stasik, Jan-Niklas Eckardt, Michael Kramer, et al.
Cancers
|
April 30, 2021
Loss-of-Function Mutations of <i>BCOR</i> Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia
Jan-Niklas Eckardt, Sebastian Stasik, Michael Kramer, et al.
Haematologica
|
April 24, 2024
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens
David Baden, Sven Zukunft, Gema Hernandez, et al.
Page
of 43